Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Journal of Clinical Endocrinology and Metabolism(2)
Acta Pædiatrica(1)
Clinical Endocrinology(1)
Origen
scopus(4)
Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin‐like growth factor I and luteinizing hormone‐releasing hormone analogue: preliminary results
ArticleAbstract: Auxological and body composition changes were studied in three adolescent patients (2 female, 1 malePalabras claves:Body Composition, bone age, Growth hormone receptor deficiency, height velocity, insulin‐like growth factor I, luteinizing hormone‐releasing hormone analogueAutores:Bachrach L.K., Davila N., Diamond F.B., Jaime Guevara-Aguirre, Martinez A., Martinez V., Moreno Z., Rosenbloom A.L., Rosenfeld R.G., Vasconez O.Fuentes:scopusA randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency
ArticleAbstract: GH insensitivity due to GH receptor deficiency is a rare autosomal recessive condition, characterizePalabras claves:Autores:Diamond F.B., Gargosky S.E., Jaime Guevara-Aguirre, Martinez L., Martinez V., Nonoshita L., Rosenbloom A.L., Rosenfeld R.G., Vasconez O.Fuentes:scopusLong-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency
ArticleAbstract: Objective. The aim of this investigation was to study the effect of relatively high dose IGF-I theraPalabras claves:Autores:Cohen P., Fielder P.J., Jaime Guevara-Aguirre, Martinez A.L., Martinez V., Rosenbloom A.L., Rosenfeld R.G., Vasconez O., Wilson K.F.Fuentes:scopusTwo-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency
ArticleAbstract: We have reported 1-yr results of a double blind, placebo-controlled trial of recombinant human insulPalabras claves:Autores:Allen L., Gargosky S.E., Jaime Guevara-Aguirre, Martinez V., Rosenbloom A.L., Rosenfeld R.G., Vasconez O.Fuentes:scopus